Endokrynologia Polska 2/2015-Bruck syndrome – a rare syndrome of bone fragility and joint contracture and novel homozygous FKBP10 mutation


Bruck syndrome – a rare syndrome of bone fragility and joint contracture and novel homozygous FKBP10 mutation

Zespół Brucka – rzadki zespół charakteryzujący się kruchością kości, przykurczami stawowymi i nowoodkrytą homozygotyczną mutacją FKBP10

Hossein Moravej1, Hamdollah Karamifar1, Zohreh Karamizadeh1, Gholamhossein Amirhakimi1, Sepideh Atashi2, Shiva Nasirabadi3

1Department of Paediatric Endocrinology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

2Pasa University of Medical Sciences, Fasa, Iran

3Haematology Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran

Shiva Nasirabadi M.D., Namazi Hospital, Namazi Square, Shiraz, Iran, 7193711351, tel.: +98 917 914 1931, fax: +98 711 635 9056, e-mail: shiva.nasirabadi@gmail.com


Bruck syndrome is an autosomal recessive syndrome consisting of bone fragility and congenital joint contractures. According to the genotype, it has been classified into types 1 and 2. Recently, mutations in FKBP10, localised to chromosome 17q21, have been identified in some patients of Bruck syndrome. Twenty-seven patients of this syndrome have been reported so far. We present a new patient of this syndrome, with frequent fractures, congenital joint contractures, kyphoscoliosis, bilateral clubfoot, and pectus carinatum. The clinical and genetic features of all previously reported cases are also reviewed.

(Endokrynol Pol 2015; 66 (2): 170-174)


Key words: Bruck; joint contracture; osteogenesis imperfecta; arthrogryposis; FKBP10 gene novel mutation



Zespół Brucka jest autosomalną chorobą recesywną, na którą składa się kruchość kości i wrodzone przykurcze stawowe. Zgodnie z genotypem zespół ten można podzielić na typ 1 i 2. Ostatnio, u niektórych pacjentów z zespołem Brucka wykryto mutacje FKBP10, genu zlokalizowanego na chromosomie 17q21. Do tej pory zarejestrowano 27 pacjentów z tym zespołem. Autorzy przedstawiają nowego pacjenta ze zdiagnozowanym zespołem Brucka, z częstymi złamaniami, wrodzonymi przykurczami stawowymi, kifoskoliozą kręgosłupa, obustronną stopą końsko-szpotawą i klatką piersiową kurzą. Przytoczymy również kliniczne i genetyczne cechy wszystkich wcześniej potwierdzonych przypadków.

(Endokrynol Pol 2015; 66 (2): 170-174)


Słowa kluczowe: Bruck; przykurcz stawu; wrodzona łamliwość kości; Artrogrypoza; nowa mutacja genu FKBP10


Bruck syndrome (BS) is a very rare syndrome in which bone fragility is associated with congenital joint contractures. It has been considered as an autosomal recessive form of osteogenesis imperfecta (OI) [1].

In 1989 Viljoen et al. reported five children with frequent fractures and arthrogryposis multiplex [2]. Because the same disorder had been reported by Dr. Bruck in 1897 [3], Viljoen et al. suggested that the disorder be called Bruck syndrome. To the best of our knowledge, 27 cases of BS have been reported in the literature so far. The first mutations discovered in BS patients were PLOD2 mutations, but evidence for the role of chromosome 17 in Bruck syndrome has lead to identifying the FKBPIO gene as a responsible locus [4-6].

The FKBPIO gene has been located on chromosome 17q21.2 and contain 10538 base pairs and transcript to a 2888bp mRNA with 11 exons, which encodes a protein with 582 amino acids that belongs to the FKBP-type peptidyl-prolyl cis/trans isomerase (PPIase) family. FKBPIO contains four sequential peptidyl-prolyl cistrans isomerase (PPIase FKBP-type) domains at N terminal and 2 EF-hand domains (calcium-binding domain) at C terminal. This protein is known as a molecular chaperone and is located in the endoplasmic reticulum [7]. The ability of FK506 Binding Protein 10 (FKBPIO) to act as a collagen chaperone justifies its role in the pathogenesis of osteogenesis imperfecta [4, 8]. Recently, mutations in FKBPIO have been detected in a few BS patients. FKBPIO mutation is associated with phenotype heterogeneity [9].

In the present article, a case of BS with novel mutation in FKBPIO is reported from Shiraz, Iran. A brief review of clinical and genetic characteristics of all previously reported cases of BS will be discussed.

Report of the case

The patient was a four-year-old girl, the second child of a first cousin consanguineous marriage from healthy Iranian parents. She was the product of a normal pregnancy born by caesarean section due to abnormal foetal presentation. She had good Apgar scores at birth and a birth weight of 2700 grams. Another child of the family is a normal boy.

Immediately after birth, contracture of both knees and elbows were detected.

The first fracture was at eight months of age, and second fracture was at two years of age, but during the third year of her life, she had four episodes of fracture in the extremities and ribs.

In physical exam, she had short stature (height at 4 years of age was about 94 cm, between 3rd and 10th percentiles), white sclera, normal teeth, normal hearing, no dysmorphic facial features, mild pectus carinatum, kyphoscoliosis, bilateral contractures and pterygia of knees and elbows, mild bilateral clubfoot, and overriding of second and third digits of the right foot. Her cognitive function was normal (Fig. 1).

Figure 1. Photograph of the patient, flexion contracture of different joints is noted
Rycina 1. Fotografia pacjenta, widoczny jest przykurcz zgięciowy różnych stawów


Radiographic evaluation showed signs of old fractures in both lower and left upper extremities. Skull X-ray was normal without visible wormian bones. There was no positive family history for congenital joint contracture or frequent fractures.

Since she was three years old, intravenous pamidronate (1 mg/kg/day, for 3 consecutive days) was started every three months, and frequent castings were applied to decrease joint contractures.

After one year of treatment, she had only one fracture, with slight improvement of joint contractures.

Genetic study with the impression of B.S. was performed for the patient and her parents with informed consent at the Collagen Diagnostic Laboratory, University of Washington. No mutation was identified in the PLOD2 gene. Sequencing the FKBP10 gene revealed a homozygous mutation in the FKBP10 gene, which consisted of a deletion of a single cytosine nucleotide (del C) and an insertion of three adenine nucleotides in exon 1 (ins AAA) c.204delCinsAAA and/or p.His68Glnfs*92, which corresponds to a net gain of two nucleotides. This leads to a reading frame shift and the creation of a premature termination codon downstream in exon 3. This mutation has not been detected previously, and this is the first case with this mutation. Informed written consent was taken from the parents before submission of this report.

Figure 2. Photograph of the patient
Rycina 2. Fotografia pacjenta


Bruck syndrome was first reported by Dr. Bruck in 1897 [3]. Viljoen et al. in 1989 reported five children with multiple fractures and congenital joint contractures, and they suggested that this disorder be named Bruck syndrome [2]. FKBP10 mutation causes phenotype heterogeneity. It is a cause of osteogenesis imperfecta with different severities and also a cause of B.S. [8].

The first PPIase domain in FKBP10 protein contains 89 amino acids (from codon 62 to codon 150). Exon 1 of FKBP10 gene has 349 bp lengths and encodes 81 amino acids, this region is a conserved sequence and codes part of the first FKBP-type peptidyl-prolyl cistrans isomerase domain. Insertion of AAA instead of C in position 204 of cDNA and codon 68 of protein sequence substitutes histidine with glutamine residue, but translation with reading frame shift continues to codon 158 in exon 3 and then termination codon due to this mutation makes a premature peptide chain [7].

So this mutation is located around the beginning of the first PPIase FKBP-type conserved domain, and it seems to lead to a radical transformation in peptide structure and folding and results in loss of function of FKBP65 protein, which in turn has several effects: secretion of type 1 procollagen is delayed, the stabilisation of the intact trimer becomes incomplete, and hydroxylation of the telopeptide lysyl residue, which is involved in intermolecular cross-link formation in bone, is decreased. The clinical effects of these molecular changes are short stature, high incidence of joint contractures, frequent fractures, and scoliosis [5, 6]

BS has been classified into types 1 and 2 [9]. BS type 2 has been linked to mutations in PLOD2 [10, 11]. The aetiology of type 1 BS has not been determined, but it has been linked to chromosome 17, possibly region 17 P12 [12]. Recently, mutations in FKBP10, localised to chromosome 17q21, have been identified in some cases of BS [9]. These mutations are also associated with some cases of autosomal recessive osteogenesis imperfecta without arthrogryposis. Therefore, FKBP10 mutations have diverse phenotypic features, including osteogenesis imperfecta with or without congenital joint contractures [6, 11]. BS is defined as congenital joint contractures associated with multiple fractures; therefore, our patient has clinical criteria of BS, but she has no specific clinical finding that can be attributed to the novel mutation in FKBP10. Researchers that have reported BS patients with mutations in FKBP10 have not found any specific clinical difference between these patients and other BS patients. Schwarze et al. identified 38 cases of osteogenesis imperfecta with FKBP10 mutations. They also found that there is remarkable variability in phenotype even within families [4, 5, 9].

So far, to the best of our knowledge, at least 27 cases of BS have been reported. Clinical features of BS are the same in different genotypes [10]. In addition to multiple bone fractures and congenital joint contractures, patients commonly have short stature, skull wormian bones, and kyphoscoliosis.

Most but not all of the cases had normal teeth, white sclera, normal cognitive functions, and normal hearing. A few cases had dysmorphic features including triangular face and brachycephaly [13-19]. Most BS cases treated with pamidronate had good to fair response. Therefore, pamidronate therapy with the same doses used in OI is recommended for these patients. Important clinical and genetic features of all reported cases of BS are presented in Table I [20, 21].

Table I. Clinical and genetic features of all reported cases of Brack syndrome. Fr. – Fracture; cont. – Contracture; St. – Stature; Wt. – Weight; LT – Length
Tabela I. Kliniczne i genetyczne cechy wszystkich zarejestrowanych przypadków zespołu Bracka. Fr. – złamanie; cont. – przykurcz; St: budowa ciała; Wt – masa ciała; LT – długość

No Ref. No. Origin Sex Freq. fr. Joint cont. Short St. Teeth Sclera Wormian  bones
1 [2] South Africa F + + + Nl White +
2 [2] South Africa M + + + Nl White +
3 [2] Zimbabwe M + + + Nl White  
4 [2] Zimbabwe M + + + Nl White  
5 [2] Zimbabwe F + + + Nl White  
6 [11] Turkey F + +   Nl White  
7 [15] Iraq F + + + + +  
8 [11] South Africa M + + +   White +
9 [20] Pakistan M + + + Nl White +
10 [11] South Africa F + +       +
11 [11] Caucasian F + + + Nl White +
12 [12] Turkey M + + +   Blue gray +
13 [19] Belgium M + + + Nl White +
14 [19] Africa F + +       +
15 [19] Belgium? Fienish M + + + Nl White +
16 [17] Egypt M + +   Nl White +
17 [14] Germany M + + + Mild problem White +
18 [1] India M + +     White +
19 [9] Saudi F + + +   White  
20 [9] Saudi F + +        
21 [9] Saudi M + + +      
22 [9] Saudi M + + +      
23 [9] Saudi M + + +      
24 [16] USA M + + + Nl White  
25 [18] France F + +       +
26 [12] Turkey M + +     Blue  
27 [21] India M + +   Nl Blue  
28 Present report Shiraz-lran F + + + Nl White -

Table I. Clinical and genetic features of all reported cases of Brack syndrome. Fr. – Fracture; cont. – Contracture; St. – Stature; Wt. – Weight; LT – Length (cont.)
Tabela I. Kliniczne i genetyczne cechy wszystkich zarejestrowanych przypadków zespołu Bracka. Fr. – złamanie; cont. – przykurcz; St: budowa ciała; Wt – masa ciała; LT – długość (cd.)

No Kyphoscoliosis Intelligence Dysmorphic face Birth Wt. Birth Lt. Mutation Hearing
1 +           Nl
2 +            
3 +            
4 +            
5 +            
6   Nl +     FKBP10 Homozygous (c.831dupC) Nl
7 +       50 FKBP10 Homozygous (c.1023insGGAGAATT) (p.T342GfsX367)  
8   Nl   2580 39 FKBP10 Homozygous (c.831dup)  
9 +           Nl
10           FKBP10 (compound heterozygous) p.(Gly278Argfs_95)/p.(Glu426Argfs_54)  
11     +     FKBP10 (compound heterozygous) p.(Gly278Argfs_95)/p.(Arg115Gln)  
12   Nl   3000   PL0D2  
13   Nl - 3300 47    
14 +     2300      
15 + Nl - 3650     Nl
16 +   +        
17 +     3070 49    
18       1700      
19   Nl - 2500   FKBP10 Homozygous (c.743dupC) (p.Q249TfsX12)  
20 + Nl -     FKBP10 Homozygous (c.743dupC) (p.Q249TfsX12)  
21 + Nl       FKBP10 Homozygous (c.743dupC) (p.Q249TfsX12)  
22 + Nl       FKBP10 Homozygous (c.743dupC) (p.Q249TfsX12)  
23   Near normal       FKBP10 Homozygous (c.831dupC) p.(Gly278Argfs_95)  
24 + Nl         Nl
25       2900 50    
26       2640 46    
28 + Nl -     FKBP10 Homozygous (c.204delCinsAAA) (p.His68Glnfs*92) Nl

According to the expanding number of cases of Bruck syndrome, it is necessary for physicians to have more information about clinical and paraclinical aspects of this disorder.

It is recommended that patients with multiple fractures and joint contracture have detailed clinical and paraclinical evaluation for detection of this disease.


  1. Datta V, Sinha A, Saili A et al. Bruck syndrome. Indian J Pediatr 2005; 72: 441–442.
  2. Viljoen D, Versfeld G, Beighton P Osteogenesis imperfecta with congenital joint contractures (Bruck syndrome). Clin Genet 1989; 36: 122-126.
  3. Bruck A. Multiple fractures associated with joint ankylosis and muscle atrophy. Dtsch Med Wochenschr 1897; 23: 152-155.
  4. Alanay Y, Avaygan H, Camacho N et al. Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 2010; 86: 551-559.
  5. Bank RA, Robins SP, Wijmenga C et al. Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. Proc Natl Acad Sci U S A 1999; 96: 1054-1058.
  6. Shaheen R, Al-Owain M, Sakati N et al. FKBP10 and Bruck syndrome: phenotypic heterogeneity or call for reclassification? Am J Hum Genet 2010; 87: 306-307; author reply 308.
  7. Flicek P, Ahmed I, Amode MR et al. Ensembl 2013. Nucleic Acids Res 2013; 41: D48-55.
  8. Ishikawa Y, Vranka J, Wirz J et al. The rough endoplasmic reticulum-resident FK506-binding protein FKBP65 is a molecular chaperone that interacts with collagens. J Biol Chem 2008; 283: 31584-31590.
  9. Shaheen R, Al-Owain M, Faqeih E, et al. Mutations in FKBP10 cause both Bruck syndrome and isolated osteogenesis imperfecta in humans. Am J Med Genet A 2011; 155A: 1448-1452.
  10. Ha-Vinh R, Alanay Y, Bank RA et al. Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PEOD2. Am J Med Genet A 2004; 131: 115-120.
  11. Kelley BP, Malfait F, Bonafe F et al. Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome. J Bone Miner Res 2011; 26: 666-672.
  12. Yapicioglu H, Ozcan K, Arikan O et al. Bruck syndrome: osteogenesis imperfecta and arthrogryposis multiplex congenita. Ann Trop Paediatr 2009; 29: 159-162.
  13. Mokete F, Robertson A, Viljoen D et al. Bruck syndrome: congenital joint contractures with bone fragility. J Orthop Sci 2005; 10: 641-646.
  14. Brenner RE, Vetter U, Stoss H et al. Defective collagen fibril formation and mineralization in osteogenesis imperfecta with congenital joint contractures (Bruck syndrome). Eur J Pediatr 1993; 152: 505-508.
  15. Breslau-Siderius EJ, Engelbert RH, Pals G et al. Bruck syndrome: a rare combination of bone fragility and multiple congenital joint contractures. J Pediatr Orthop B 1998; 7: 35-38.
  16. McPherson E, Clemens M. Bruck syndrome (osteogenesis imperfecta with congenital joint contractures): review and report on the first North American case. Am J Med Genet 1997; 70: 28-31.
  17. Blacksin MF, Pletcher BA, David M. Osteogenesis imperfecta with joint contractures: bruck syndrome. Pediatr Radiol 1998; 28: 117-119.
  18. Cuillier F, Alessandri JL, Lemaire P et al. Bruck syndrome: second antenatal diagnosis. Fetal Diagn Ther 2007; 22: 23-28.
  19. Feroy JG, Nuytinck F, De Paepe A et al. Bruck syndrome: neonatal presentation and natural course in three patients. Pediatr Radiol 1998; 28: 781-789.
  20. Brady AF, Patton MA. Osteogenesis imperfecta with arthrogryposis multiplex congenita (Bruck syndrome) – evidence for possible autosomal recessive inheritance. Clin Dysmorphol 1997; 6: 329-336.
  21. Sharma NF, Anand JS. Osteogenesis Imperfecta with Arthrogryposis Multiplex Congenita. J Indian Med Assoc 1964; 43: 124-126.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl